Sean E. Aeder

Array ( [id] => 11992487 [patent_doc_number] => 20170296640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers' [patent_app_type] => utility [patent_app_number] => 15/436385 [patent_app_country] => US [patent_app_date] => 2017-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 42046 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15513293 [patent_doc_number] => 10563224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Replication defective adenovirus vector in vaccination [patent_app_type] => utility [patent_app_number] => 15/433934 [patent_app_country] => US [patent_app_date] => 2017-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 45105 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11664521 [patent_doc_number] => 20170153241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'CELL RESPONSE ASSAY FOR CANCER AND METHODS OF PRODUCING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 15/430445 [patent_app_country] => US [patent_app_date] => 2017-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12163 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15430445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11850305 [patent_doc_number] => 20170224797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'Cancer Therapy Using a Vaccine in Combination with a Cell-Based Immunotherapeutic Agent' [patent_app_type] => utility [patent_app_number] => 15/428871 [patent_app_country] => US [patent_app_date] => 2017-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5222 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17351703 [patent_doc_number] => 11226334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-18 [patent_title] => Method, biomarker and diagnostic agent for detection of high-risk prostate cancer [patent_app_type] => utility [patent_app_number] => 16/073217 [patent_app_country] => US [patent_app_date] => 2017-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 13430 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15268211 [patent_doc_number] => 20190382839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => COPANLISIB BIOMARKERS [patent_app_type] => utility [patent_app_number] => 16/074037 [patent_app_country] => US [patent_app_date] => 2017-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11944443 [patent_doc_number] => 20170248594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'Assay for Detection of Chimeric Antigen Receptor T Cells' [patent_app_type] => utility [patent_app_number] => 15/417292 [patent_app_country] => US [patent_app_date] => 2017-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5029 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17712334 [patent_doc_number] => 11376313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-05 [patent_title] => Cancer treatment [patent_app_type] => utility [patent_app_number] => 16/073247 [patent_app_country] => US [patent_app_date] => 2017-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 28 [patent_no_of_words] => 15566 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12627084 [patent_doc_number] => 20180100858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-12 [patent_title] => PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA [patent_app_type] => utility [patent_app_number] => 15/414456 [patent_app_country] => US [patent_app_date] => 2017-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74289 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15414456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16756623 [patent_doc_number] => 10975161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Molecules that bind prostate specific membrane antigen (PSMA) [patent_app_type] => utility [patent_app_number] => 16/069495 [patent_app_country] => US [patent_app_date] => 2017-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 39 [patent_no_of_words] => 48738 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1070 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16650010 [patent_doc_number] => 10927173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Humanized, mouse or chimeric anti-CD47 monoclonal antibodies [patent_app_type] => utility [patent_app_number] => 16/068874 [patent_app_country] => US [patent_app_date] => 2017-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 31 [patent_no_of_words] => 29807 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16973080 [patent_doc_number] => 11069054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-20 [patent_title] => System and method for automated detection and monitoring of dysplasia and administration of immunotherapy and chemotherapy [patent_app_type] => utility [patent_app_number] => 15/403940 [patent_app_country] => US [patent_app_date] => 2017-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 10761 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 409 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15403940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11569860 [patent_doc_number] => 20170108503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'METHODS AND SYSTEMS OF USING EXOSOMES FOR DETERMINING PHENOTYPES' [patent_app_type] => utility [patent_app_number] => 15/394684 [patent_app_country] => US [patent_app_date] => 2016-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 149 [patent_figures_cnt] => 149 [patent_no_of_words] => 80462 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15394684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17060359 [patent_doc_number] => 11104949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-31 [patent_title] => Inhibitors of a-tubulin acetylation for the treatment of pain [patent_app_type] => utility [patent_app_number] => 16/069818 [patent_app_country] => US [patent_app_date] => 2016-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11728 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11554223 [patent_doc_number] => 20170100469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'COMPOSITIONS AND METHODS COMPRISING KLK3 OR FOLH1 ANTIGEN' [patent_app_type] => utility [patent_app_number] => 15/388503 [patent_app_country] => US [patent_app_date] => 2016-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 41478 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15388503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11670410 [patent_doc_number] => 20170159131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'PREDICTING CANCER OUTCOME' [patent_app_type] => utility [patent_app_number] => 15/379237 [patent_app_country] => US [patent_app_date] => 2016-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13898 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15379237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13829065 [patent_doc_number] => 20190018017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => Integrated Analysis To Determine Prognosis After Treatment For Primary Breast Cancer [patent_app_type] => utility [patent_app_number] => 16/060638 [patent_app_country] => US [patent_app_date] => 2016-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4386 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14870787 [patent_doc_number] => 20190285635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => CNPY2 ISOFORM 2 AND THE USE THEREOF AS MOLECULAR MARKER FOR COLORECTAL CANCER [patent_app_type] => utility [patent_app_number] => 16/464261 [patent_app_country] => US [patent_app_date] => 2016-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12030847 [patent_doc_number] => 20170320947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'HETERODIMERIC ANTIBODIES THAT BIND CD3 AND PSMA' [patent_app_type] => utility [patent_app_number] => 15/372360 [patent_app_country] => US [patent_app_date] => 2016-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 27189 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13462555 [patent_doc_number] => 20180282820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => MONITORING TREATMENT OR PROGRESSION OF MYELOMA [patent_app_type] => utility [patent_app_number] => 15/776770 [patent_app_country] => US [patent_app_date] => 2016-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776770 [rel_patent_id] =>[rel_patent_doc_number] =>)